BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24240584)

  • 21. Alpha 1 antichymotrypsin genotype is associated with increased risk of prostate carcinoma and PSA levels.
    Licastro F; Bertaccini A; Porcellini E; Chiappelli M; Pernetti R; Sanguedolce F; Marchiori D; Martorana G
    Anticancer Res; 2008; 28(1B):395-9. PubMed ID: 18383875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of IGFBP3 gene polymorphisms on IGFBP3 serum levels and the risk of prostate cancer in low-risk Korean men.
    Park K; Kim JH; Jeon HG; Byun SS; Lee E
    Urology; 2010 Jun; 75(6):1516.e1-7. PubMed ID: 20350746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations Between Gene Polymorphisms of Vascular Endothelial Growth Factor and Prostate Cancer.
    Drobková H; Jurečeková J; Sivoňová MK; Mazuchová J; Škorvanová M; Šarlinová M; Halašová E; Kliment J
    Anticancer Res; 2019 Jun; 39(6):2903-2909. PubMed ID: 31177128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA--a simultaneous study of 130 potentially functional SNPs in 14 candidate genes.
    Enjuanes A; Benavente Y; Hernández-Rodríguez J; Queralt C; Yagüe J; Jares P; de Sanjosé S; Campo E; Cid MC
    Rheumatology (Oxford); 2012 May; 51(5):841-51. PubMed ID: 22258388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
    Fukuda H; Tsuchiya N; Narita S; Kumazawa T; Horikawa Y; Inoue T; Saito M; Yuasa T; Matsuura S; Satoh S; Ogawa O; Habuchi T
    Oncol Rep; 2007 Nov; 18(5):1155-63. PubMed ID: 17914566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer.
    Lee SJ; Lee SY; Jeon HS; Park SH; Jang JS; Lee GY; Son JW; Kim CH; Lee WK; Kam S; Park RW; Park TI; Kang YM; Kim IS; Jung TH; Park JY
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):571-5. PubMed ID: 15767331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1132-40. PubMed ID: 22317880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population.
    Mittal RD; Mandal RK; Gangwar R
    Mech Ageing Dev; 2012 Apr; 133(4):127-32. PubMed ID: 22019847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between vascular endothelial growth factor rs699947 polymorphism and the risk of three major urologic neoplasms (bladder cancer, prostate cancer, and renal cell carcinoma): A meta-analysis involving 11,204 subjects.
    Song Y; Hu J; Chen Q; Guo J; Zou Y; Zhang W; Chen X; Hu W; Huang P
    Gene; 2018 Dec; 679():241-252. PubMed ID: 30195633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population.
    Onen IH; Konac E; Eroglu M; Guneri C; Biri H; Ekmekci A
    Mol Biol Rep; 2008 Mar; 35(1):17-22. PubMed ID: 17216542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer.
    Langsenlehner T; Langsenlehner U; Renner W; Krippl P; Mayer R; Wascher TC; Kapp KS
    Eur J Cancer; 2008 Jul; 44(11):1572-6. PubMed ID: 18514506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphisms in COX-2 gene influence prostate cancer susceptibility in a northern Indian cohort.
    Mandal RK; Mittal RD
    Arch Med Res; 2011 Oct; 42(7):620-6. PubMed ID: 22023987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressiveness.
    Sa-Nguanraksa D; Chuangsuwanich T; Pongpruttipan T; Kummalue T; Rojananin S; Ratanawichhitrasin A; Prasarttong-Osoth P; Chuthatisith S; Pisarnturakit P; Aeumrithaicharoenchok W; Rushatamukayanunt P; Lohsiriwat V; Boonsripitayanon M; Malasit P; O-Charoenrat P
    Mol Med Rep; 2013 Oct; 8(4):1242-50. PubMed ID: 23904001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor -2578 A/C, -460 T/C and +405 G/C polymorphisms in polycystic ovary syndrome.
    Vural P; Küskü-Kiraz Z; Doğru-Abbasoğlu S; Cil E; Karadağ B; Akgül C; Uysal M
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):57-60. PubMed ID: 19631445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population.
    Patiño-García B; Arroyo C; Rangel-Villalobos H; Soto-Vega E; Velarde-Félix JS; Gabilondo F; Sandoval-Ramirez L; Figuera LE
    Rev Invest Clin; 2007; 59(1):25-31. PubMed ID: 17569297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
    Absenger G; Szkandera J; Stotz M; Pichler M; Winder T; Langsenlehner T; Langsenlehner U; Samonigg H; Renner W; Gerger A
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E96-102. PubMed ID: 23625573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular endothelial growth factor gene +405 C/G polymorphism is associated with susceptibility to advanced stage endometriosis.
    Kim SH; Choi YM; Choung SH; Jun JK; Kim JG; Moon SY
    Hum Reprod; 2005 Oct; 20(10):2904-8. PubMed ID: 15979997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association of ENA-78, IP-10 and VEGF gene polymorphism with idiopathic pulmonary fibrosis].
    Liu L; Dai HP; Xiao B; Zhang S; Ban CJ; Xin P
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(38):2690-4. PubMed ID: 20137269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk.
    VanCleave TT; Moore JH; Benford ML; Brock GN; Kalbfleisch T; Baumgartner RN; Lillard JW; Kittles RA; Kidd LC
    Prostate; 2010 Mar; 70(4):341-52. PubMed ID: 19908237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between lncrna PCGEM1 polymorphisms and prostate cancer risk.
    Xue Y; Wang M; Kang M; Wang Q; Wu B; Chu H; Zhong D; Qin C; Yin C; Zhang Z; Wu D
    Prostate Cancer Prostatic Dis; 2013 Jun; 16(2):139-44, S1. PubMed ID: 23459097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.